Customer Interview
Deciphering the Role of Long Non-Coding RNA in Cancer
Researchers are using RNA-Seq to reveal how lncRNAs could be used to identify, measure, and treat cancer.
Read Article
Customer Interview
Precision Immunotherapies Using Tumor-Specific HLA Ligands
RNA-Seq and HLA typing are increasing the power and efficiency of a target discovery platform.
Read Article
Customer Video
Bringing all the omics together
Dr. Szilard Voros, CEO of Global Genomics Group (G3), shares how he and his team of researchers embarked on an ambitious journey to transform...
View VideoTruSight Oncology 500 ctDNA
Assay targeting multiple somatic variant types from plasma, including TMB and MSI
Preorder NowAccurate Identification of Cancer Biomarkers Paves the Way for Personalized Medicine
TruSight Tumor 170 Panel enables translational researchers to seek answers to multiple questions in one assay
Read ArticleTraining and Webinars
Illumina offers webinars and free online training courses to get the most out of your experiments and products
View Webinars View CoursesFeatured Tool
MyIllumina Tools
Get support with a full suite of tools that guide you, from start to finish
Sign in or RegisterPopular Tools
MyIllumina Customer Dashboard
Sign In or Learn MoreLibrary Prep and Array Kit Selector
Launch ToolBaseSpace Sequence Hub
Sign In or Learn MoreCustom Protocol Selector
Build ProtocolDesignStudio Custom Assay Designer
Sign In or Learn More
See More Tools
Featured News
The Power and Promise of Liquid Biopsies
By: Dr. Phil Febbo, Chief Medical Officer at Illumina
Read Article| Date | Publication | Title |
|---|---|---|
| 16-Oct-2019 | NPR | A Boy's Mysterious Illness Leads His Family On A Diagnostic Odyssey |
| 09-Oct-2019 | Yahoo! Finance | Illumina Inks Deal to Commercialize NGS-Based IVD Kits |
| 30-Sep-2019 | ClinicalOMICs | Illumina and the Broad Co-Developing Open-Source Secondary Analysis Software |